A detailed history of Jnba Financial Advisors transactions in Medtronic PLC stock. As of the latest transaction made, Jnba Financial Advisors holds 28,108 shares of MDT stock, worth $2.53 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
28,108
Previous 28,609 1.75%
Holding current value
$2.53 Million
Previous $2.49 Million 11.27%
% of portfolio
0.23%
Previous 0.26%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$78.71 - $87.02 $39,433 - $43,597
-501 Reduced 1.75%
28,108 $2.21 Million
Q1 2024

Apr 26, 2024

SELL
$82.84 - $88.09 $29,076 - $30,919
-351 Reduced 1.21%
28,609 $2.49 Million
Q4 2023

Feb 07, 2024

BUY
$69.43 - $83.43 $17,496 - $21,024
252 Added 0.88%
28,960 $2.39 Million
Q3 2023

Nov 02, 2023

BUY
$78.22 - $90.4 $860 - $994
11 Added 0.04%
28,708 $2.25 Million
Q2 2023

Aug 03, 2023

BUY
$79.47 - $91.38 $6,516 - $7,493
82 Added 0.29%
28,697 $2.53 Million
Q1 2023

May 01, 2023

SELL
$76.72 - $87.58 $6,137 - $7,006
-80 Reduced 0.28%
28,615 $2.31 Million
Q4 2022

Feb 06, 2023

SELL
$76.18 - $87.74 $88,444 - $101,866
-1,161 Reduced 3.89%
28,695 $2.23 Million
Q3 2022

Nov 07, 2022

BUY
$80.75 - $95.31 $14,050 - $16,583
174 Added 0.59%
29,856 $2.41 Million
Q2 2022

Jul 22, 2022

SELL
$87.4 - $113.09 $299,082 - $386,993
-3,422 Reduced 10.34%
29,682 $2.66 Million
Q1 2022

Apr 29, 2022

SELL
$100.58 - $112.38 $66,885 - $74,732
-665 Reduced 1.97%
33,104 $3.67 Million
Q4 2021

Feb 03, 2022

SELL
$99.53 - $127.75 $4,180 - $5,365
-42 Reduced 0.12%
33,769 $3.49 Million
Q3 2021

Nov 10, 2021

SELL
$122.75 - $135.17 $3,068 - $3,379
-25 Reduced 0.07%
33,811 $4.24 Million
Q2 2021

Aug 04, 2021

SELL
$118.19 - $131.5 $81,196 - $90,340
-687 Reduced 1.99%
33,836 $4.2 Million
Q1 2021

May 03, 2021

BUY
$111.18 - $119.74 $84,385 - $90,882
759 Added 2.25%
34,523 $4.08 Million
Q4 2020

Jan 25, 2021

SELL
$100.57 - $117.14 $581,495 - $677,303
-5,782 Reduced 14.62%
33,764 $3.96 Million
Q3 2020

Nov 05, 2020

SELL
$90.13 - $108.78 $197,474 - $238,336
-2,191 Reduced 5.25%
39,546 $4.11 Million
Q2 2020

Jul 24, 2020

SELL
$84.11 - $103.33 $74,269 - $91,240
-883 Reduced 2.07%
41,737 $3.83 Million
Q1 2020

May 01, 2020

SELL
$72.92 - $121.3 $47,398 - $78,845
-650 Reduced 1.5%
42,620 $3.84 Million
Q4 2019

Feb 10, 2020

SELL
$104.49 - $114.54 $19,644 - $21,533
-188 Reduced 0.43%
43,270 $4.91 Million
Q3 2019

Nov 01, 2019

BUY
$98.02 - $111.18 $64,399 - $73,045
657 Added 1.54%
43,458 $4.72 Million
Q2 2019

Jul 26, 2019

BUY
$84.15 - $99.38 $72,032 - $85,069
856 Added 2.04%
42,801 $4.17 Million
Q1 2019

May 01, 2019

SELL
$82.45 - $93.79 $42,626 - $48,489
-517 Reduced 1.22%
41,945 $3.82 Million
Q4 2018

Feb 07, 2019

BUY
$85.8 - $99.49 $3.43 Million - $3.98 Million
40,012 Added 1633.14%
42,462 $3.86 Million
Q3 2018

Nov 01, 2018

SELL
$85.91 - $99.17 $3.56 Million - $4.11 Million
-41,447 Reduced 94.42%
2,450 $241,000
Q1 2018

May 07, 2018

SELL
$76.55 - $87.26 $126,307 - $143,979
-1,650 Reduced 3.62%
43,897 $43.9 Million
Q3 2017

Nov 13, 2017

SELL
$77.71 - $84.6 $10,490 - $11,421
-135 Reduced 0.3%
45,547 $3.54 Million
Q2 2017

Aug 14, 2017

BUY
N/A
45,682
45,682 $4.05 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $120B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.